Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial
Thrombosis and Haemostasis (2021) - Comments
doi: 10.1055/a-1485-2372  issn: 0340-6245  issn: 2567-689x  pubmed: 33865239 

Behnood Bikdeli, Azita H Talasaz, Farid Rashidi, Hooman Bakhshandeh, Farnaz Rafiee, Samira Matin, Elahe Baghizadeh, Parisa Rezaeifar, Sepehr Jamalkhani, Ouria Tahamtan, Babak Sharif-Kashani, Mohammad Taghi Beigmohammadi, Mohsen Farrokhpour, Seyed Hashem Sezavar, Pooya Payandemehr, Ali Dabbagh, Keivan Gohari Gohari Moghadam, Hossein Khalili, Mahdi Yadollahzadeh, Taghi Riahi